臨牀透析 Vol.23 No.12(2-3)


特集名 合併症を伴った維持透析患者の栄養管理
題名 内科系慢性疾患 (3) 慢性肝炎・肝硬変
発刊年月 2007年 11月
著者 岩田 加壽子 三重大学医学部附属病院栄養管理部栄養指導管理室・管理栄養士
著者 垣内 雅彦 三重大学大学院医学系研究科病態制御医学講座消化器内科学
【 要旨 】 腎不全患者の貧血治療はrHuEPO治療や鉄補給により大きく進歩したが,一方,鉄過剰による障害もみられる.透析患者のHCV抗体陽性率は一般の約10倍と高率である.C型慢性肝炎患者では鉄過剰をきたしやすく,鉄依存性フリーラジカルが病態を悪化させることが明らかになっている.慢性肝炎・肝硬変を合併した維持透析患者への栄養管理では,とくに血清フェリチン値に注意し,肝機能と腎機能検査値そして栄養評価によりそのバランスを考慮しながら栄養処方を設定していく必要がある.
Theme Nutritional Managements for Maintenance Dialysis Patients with Clinical Complications
Title Dietary iron restriction in dialysis patients with chronic hepatitis C or liver cirrhosis
Author Kazuko Iwata Department of Food and Nutrition Services, Mie Unibersity Hospital
Author Masahiko Kaito Department of Gastroenterology and Hepatology, Division of Clinical Medicine and Biomedical Science, Institute of Medical Science, Mie University Graduate School of Medicine
[ Summary ] The administration of recombinant human erythropoietin and iron has provided dramatic progress in the treatment of anemia associated with chronic renal failure. However, excess iron can be harmful to organisms, in part through the generation of free radicals. Excess divalent iron generates free radicals, mainly via Fenton chemistry. The ratio of anti-HCV antibody positive results in patients receiving dialysis was ten times that of normal subjects. Most patients with chronic hepatitis C are exposed to iron-induced oxidative stress. Iron reduction therapy, both in the form of phlebotomies or dietary iron restriction, improved hepatic inflammation and lowered aminotransferase levels in CH-C patients. When treating dialysis patients with chronic hepatitis or liver cirrhosis we should be careful of iron overloads in nutritional treatment.
戻る